New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
08:21 EDTACADACADIA jumps 161% to $6.00 after positive Parkinson's trial results
News For ACAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
07:19 EDTACADACADIA price target raised to $50 from $42 at Jefferies
Jefferies raised its price target for ACADIA shares to $50 after increasing its Nuplazid sales estimates in Parkinson's disease psychosis. The firm believes Nuplazidís efficacy and safety profile could lead to a strong launch and keeps a Buy rating on ACADIA.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use